Clinical Trial Update: A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients [Phase 3]

View source ↗

Summary

This update describes a Phase 3 trial evaluating Petosemtamab versus investigator's choice monotherapy in previously treated head and neck squamous cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Petosemtamab

Snippet

Sponsor: Merus B.V. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING